Tower Research Capital (TRC)’s VanEck Vectors Generic Drugs ETF GNRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-240
Closed -$6K 4966
2016
Q3
$6K Hold
240
﹤0.01% 2504
2016
Q2
$6K Sell
240
-51
-18% -$1.28K ﹤0.01% 3328
2016
Q1
$7K Buy
+291
New +$7K ﹤0.01% 2476